Bleeding Disorders Panel
Use
This test is designed for individuals with relevant clinical features who have a diagnosed or suspected inherited bleeding disorder. It serves to identify genetic variants associated with bleeding diatheses, aiding in the confirmation of the diagnosis and potentially guiding treatment decisions.
Special Instructions
This test utilizes next-generation sequencing with CNV detection on either the Exome or Genome platforms. Ensure that the correct specimen type, as specified for each platform, is submitted. STAT testing is available to expedite results.
Limitations
The test analyzes 85 genes associated with various bleeding disorders, identifying sequence variants and copy number changes. However, it may not detect all genetic variants responsible for such disorders, especially those outside the tested gene set or within regions poorly covered by the sequencing technology.
New York Approved
Methodology
NGS (CGP)
Biomarkers
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided